Detalles de la búsqueda
1.
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
Pharmacol Res;
201: 107092, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38311014
2.
Correction: Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
Br J Cancer;
127(7): 1378-1379, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953714
3.
RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells.
Front Oncol;
12: 826617, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35402225
4.
Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
Br J Cancer;
124(9): 1566-1580, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33658640
5.
Combined inhibition of Ref-1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co-culture models.
J Cell Mol Med;
25(2): 784-800, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33274592
6.
Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1.
J Med Chem;
62(4): 1971-1988, 2019 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30653918
7.
Small molecule activation of apurinic/apyrimidinic endonuclease 1 reduces DNA damage induced by cisplatin in cultured sensory neurons.
DNA Repair (Amst);
41: 32-41, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27078577
Resultados
1 -
7
de 7
1
Próxima >
>>